Impact of specialist care in patients with newly diagnosed heart failure: A randomised controlled study

International Journal of Cardiology

Volumn 115, Issue 2, 2007, Pages 196-202

  Rao, Archana ^a   Walsh, John ^b  

^a Cardio thoracic Centre   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Chronic heart failure; Community cardiac care; Open access echocardiography

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LOSARTAN; PERINDOPRIL; RAMIPRIL; SPIRONOLACTONE;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOLOGY; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; NURSE; PATIENT CARE; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEX RATIO;

AGED; CARDIOLOGY; FAMILY PRACTICE; FEASIBILITY STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 33846394339     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.010     Document Type: Article

References (34)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med 316 23 (1987) 1429-1435
2. Packer M., Poole-Wilson P.A., Armstrong P.W., et al. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure. Circulation 100 (1999) 2312-2318
3. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Eng J Med 334 (1996) 1349-1355
4. Ho K.K., Anderson K.M., Kannel W.B., et al. Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 88 (1993) 107-115
5. Vinson J.M., Rich M.W., Sperry J.C., et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 38 (1990) 1290-1295
6. Burns R.B., McCarthy E.P., Moskowitz M.A., et al. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 45 (1997) 276-280
7. Davie A.P., Francis A.M., Caruana G.R., et al. Assessing diagnosis in heart failure: which features are of any use. QJM 86 90 (1997) 335-339
8. Wheeldon T.M., MacDonald T.M., Flucker C.J., et al. Echocardiography in chronic heart failure in the community. QJM 86 (1993) 17-23
9. Willenheimer R., Israelsson B.A., Cline C.M., et al. Simplified echocardiography in the diagnosis of heart failure. Scand Card J 31 (1997) 9-16
10. Stewart S., Marley J.E., Horowitz J.D., et al. Effects of multi-disciplinary, home based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure - a randomised controlled study. Lancet 1 59 (1999) 1077-1083
11. Rich M.W., Beckham V., Wittenberg C., et al. A multi-disciplinary intervention to prevent the re-admission of elderly patients with chronic heart failure. N Eng J Med 333 (1999) 1190-1195
12. Cline C.M.J., Israelsson B.Y.A., Willnheimer R.B., et al. Cost effective management programme for heart failure reduces hospitalisation. Heart 80 (1998) 442-446
13. Remme W.J., and Swedberg K. Task Force Report: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
14. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 325 5 (1991) 293-302
15. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared to captopril on mortality in patients with symptomatic heart failure; randomised trial - the Losartan Heart Failure Survival Study ELITE 2. Lancet 355 (2000) 1582-1587
16. Pitt B., Pierard L.A., Bilge A., et al. Effectiveness of spironolactone added to added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure - (The randomised aldactone evaluation study (RALES). Am J Cardiol 78 (1996) 902-907
17. Hrowitz J.D. Home-based intervention: the next step in treatment of chronic heart failure?. Eur Heart J 21 (2000) 1807-1809
18. Rice D.P. Beneficiary profile: yesterday, today and tomorrow. Health Care Financ Rev 18 (1999) 23-46
19. Senni M., Triboulloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community - trends in incidence and survival in a 10-year period. Arch Intern Med 159 (1999) 29-34
20. Schocken D.D., Arrieta M.I., Leaverton P.E., et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 20 (1992) 301-306
21. Krumholz H.M., Wang Y., Parent E.M., et al. Quality of care for elderly patients hospitalised with heart failure. Arch Intern Med 157 (1997) 2242-2247
22. McLalsen A., Konig G., and Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80 (1998) 437-441
23. Rich M.W., Beckham V., Wittenberg C., Leven C.L., Freedland K.E., and Carney R.M. A multi-disciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Eng J Med 333 18 (1995) 1190-1195
24. Rutten Frans H., Diederick E., and Grobbe A.W. Differences between general practitioners and cardiologists in the diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5 3 (2003) 337-344
25. CIBIS 2 Investigators and Commitees. The Cardiac Insufficiency Bisoprolol Study 2 (CIBIS2). Lancet 353 (1999) 9-13
26. Cohn J., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 5 (1991) 351-353
27. Friedman M. Older adults' symptoms and their duration before hospitalisation for heart failure. Heart Lung 26 (1997) 169-176
28. Weinberger M., Oddone E.Z., Henderson W.G., et al. Does increased access to primary care reduce hospital admissions?. N Eng J Med 334 (1996) 1441-1447
29. Ekman I., Andersson B., Ehnfors M., et al. Feasibility of a nurse-monitored, out patient-care programme for elderly patient with moderate to severe, chronic heart failure. Eur Heart J 19 (1998) 1254-1260
30. Khunti K., Hearnshaw H., Baker R., et al. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 4 (2002) 771-776
31. Department of Health. National Service Framework for Coronary Heart disease. 2000.
32. Francis C.M., Caruana L., Kearney P., Love M., Sutherland G.R., and Starkey I.R. Open-access echocardiography in management of heart failure in the community. BMJ 310 6980 (1995) 634-636
33. Fuat A., Hungin A.P., Murphy J.J., et al. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 326 (2003) 196-201
34. Davis R., Bhatia G., Sosin M., et al. Barriers to managing heart failure in primary care. BMJ 326 (2003) 883